DCVC Announcements
Deep Tech Opportunities Report
DCVC DTOR 2024: Startup thinking will help the defense and security sectors prepare for new threats
News
Latus Bio finds a better way to deliver genes to cells deep in the brain to help patients with neurodegeneration
News
Creyon Bio deal with Lilly brings up to $1 billion in payments for research on RNA-targeting drugs
Snapshot
Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells
News
Quantum Advantage: Q-CTRL’s next-generation navigation system to guide us when GPS can’t
News
Proprio’s latest FDA approval clears the way for better, AI-driven surgery
Deep Tech Opportunities Report
DCVC DTOR 2024: Industry is turning to unconventional water sources for fresh water and critical minerals
News
Lumafield raises $75 million to give manufacturers a look deep inside their products as they come out of the lab and off the line
Deep Tech Opportunities Report
DCVC DTOR 2024: How clean is cleantech from China?
Deep Tech Opportunities Report
DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now
News
In a deep-tech twofer, Brimstone aims to secure U.S. aluminum supply
Deep Tech Opportunities Report
DCVC DTOR 2024: New storage and generation technologies will make the electrical grid cleaner and more resilient
DCVC Announcements
22
In The Media
359
Endpoints News
With a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnership
Creyon Bio
Endpoints News
Biotech seed rounds sink to lowest level in years as industry slump drags on [Kiersten Stead featured]
Bloomberg
Khosla-Backed Energy Startup Nabs $258 Million to Help Power Data Centers
Axios
Clinical-stage biotech Solu valued at $100M after raising $41M Series A
Solu Therapeutics
2024 Deep Tech Opportunities Report
DCVC’s partners share their thoughts on the most compelling areas of prospective deep tech investment in 2024 and beyond.